Matteo Levisetti

Former Chief Medical OfficeratCue Biopharma· In proxies 2024–2025

Pay in FY2025+2% from the year before · Cue Biopharma stock -72.0% the same year

Matteo Levisetti was paid $1.2M in FY2025 (Dec), up 2%. Cue Biopharma stock fell 72.0% that year.

Pay$100 in the stock at the end of FY23 → $12

Pay is from the Summary Compensation Table of each Cue Biopharma proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

CUE
Cue BiopharmaPublic company · 2 yr
- Former Chief Medical Officer2024 – Present · 2 yrStock in role -77%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?